Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Islet Amyloid Polypeptide (IAPP), also known as Amylin, is a 37-amino acid peptide hormone co-secreted with insulin from pancreatic β-cells. It plays a role in glucose homeostasis by inhibiting glucagon secretion, slowing gastric emptying, and promoting satiety. In type II diabetes, IAPP can aggregate into amyloid fibrils, leading to islet amyloidosis and contributing to β-cell dysfunction and death. It is encoded by a gene on chromosome 12p12.1 and belongs to the calcitonin gene-related peptide family.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Islet Amyloid Polypeptide (IAPP).